Time Spent <70 mg/dL - Main Phase, Day and Night
Percentage of CGM Measured Glucose Values <70 mg/dl during study Main Phase
Time Spent <70 mg/dL - Main Phase, Day Only
Percentage of CGM Measured Glucose Values <70 mg/dl during study Main Phase, day only (07:00 - 23:00)
Time in Range 70-180 mg/dL - Main Phase, Day and Night
Percentage of CGM Measured Glucose Values in range 70-180 mg/dl during study Main Phase
Time in Range 70-180 mg/dL - Main Phase, Night Only
Percentage of CGM Measured Glucose Values in range 70-180 mg/dl during study Main Phase, night only (23:00 - 07:00)
Time in Range 70-180 mg/dL - Main Phase, Day Only
Percentage of CGM Measured Glucose Values in range 70-180 mg/dl during study Main Phase, day only (07:00 - 23:00)
Mean Sensor Glucose - Main Phase, Day and Night
Mean CGM sensor glucose during study Main Phase
Mean Sensor Glucose - Main Phase, Night Only
Mean CGM sensor glucose during study Main Phase, night only (23:00 - 07:00)
Mean Sensor Glucose - Main Phase, Day Only
Mean CGM sensor glucose during study Main Phase, day only (07:00 - 23:00)
Glucose Coefficient of Variation - Main Phase, Day and Night
CGM Glucose Coefficient of Variation (CV) during study Main Phase
Glucose Coefficient of Variation - Main Phase, Night Only
CGM Glucose Coefficient of Variation (CV) during study Main Phase, night only (23:00 - 07:00)
Glucose Coefficient of Variation - Main Phase, Day Only
CGM Glucose Coefficient of Variation (CV) during study Main Phase, day only (07:00 - 23:00)
Glucose Standard Deviation - Main Phase, Day and Night
CGM Glucose Standard Deviation (SD) during study Main Phase
Glucose Standard Deviation - Main Phase, Night Only
CGM Glucose Standard Deviation (SD) during study Main Phase, night only (23:00 - 07:00)
Glucose Standard Deviation - Main Phase, Day Only
CGM Glucose Standard Deviation (SD) during study Main Phase, day only (07:00 - 23:00)
Time Spent >180 mg/dL - Main Phase, Day and Night
Percentage of CGM Measured Glucose Values >180 mg/dl during study Main Phase
Time Spent >180 mg/dL - Main Phase, Night Only
Percentage of CGM Measured Glucose Values >180 mg/dl during study Main Phase, night only (23:00 to 07:00)
Time Spent >180 mg/dL - Main Phase, Day Only
Percentage of CGM Measured Glucose Values >180 mg/dl during study Main Phase, day only (07:00 - 23:00)
Time Spent <50 mg/dL - Main Phase, Day and Night
Percentage of CGM Measured Glucose Values <50 mg/dl during study Main Phase
Time Spent <50 mg/dL - Main Phase, Night Only
Percentage of CGM Measured Glucose Values <50 mg/dl during study Main Phase, night only (23:00 to 07:00)
Time Spent <50 mg/dL - Main Phase, Day Only
Percentage of CGM Measured Glucose Values <50 mg/dl during study Main Phase, day only (07:00 - 23:00)
Time Spent <60 mg/dL - Main Phase, Day and Night
Percentage of CGM Measured Glucose Values <60 mg/dl during study Main Phase
Time Spent <60 mg/dL - Main Phase, Night Only
Percentage of CGM Measured Glucose Values <60 mg/dl during study Main Phase, night only (23:00 - 07:00)
Time Spent <60 mg/dL - Main Phase, Day Only
Percentage of CGM Measured Glucose Values <60 mg/dl during study Main Phase, day only (07:00 - 23:00)
LBGI - Main Phase, Day and Night
Low Blood Glucose Index (LBGI) - Main Phase, Day and Night. The LGBI metric is used to quantify the risk of hypoglycemia. A higher LBGI implies more mild hypoglycemic events or less severe hypoglycemic events.
LBGI - Main Phase, Night Only
Low Blood Glucose Index (LBGI) - Main Phase, night only (23:00 - 07:00). The LGBI metric is used to quantify the risk of hypoglycemia. A higher LBGI implies more mild hypoglycemic events or less severe hypoglycemic events.
LBGI - Main Phase, Day Only
Low Blood Glucose Index (LBGI) - Main Phase, day only (07:00 - 23:00). The LGBI metric is used to quantify the risk of hypoglycemia. A higher LBGI implies more mild hypoglycemic events or less severe hypoglycemic events.
AOC 70 mg/dL - Main Phase, Day and Night
Area Over the Curve (AOC) 70 mg/dL - Main Phase, Day and Night. The hypoglycemia AOC is scaled to the number of CGM readings so the time factor cancels out. Technically, the units would be mg/dl, but this might seem unintuitive since it is incremental relative to a threshold. For example, a hypoglycemia AOC of 1 mg/dl can denote a glucose of 60 mg/dl for 10% of the time (10 mg/dl below threshold * 10% = 1 mg/dl) or 65 mg/dl for 20% of the time (5 mg/dl below threshold * 20% = 1 mg/dl). Note that it is based on relative (%) rather than absolute time so there is no time element in the resulting units.
AOC 70 mg/dL - Main Phase, Night Only
Area Over the Curve (AOC) 70 mg/dL - Main Phase, night only (23:00 - 07:00). The hypoglycemia AOC is scaled to the number of CGM readings so the time factor cancels out. Technically, the units would be mg/dl, but this might seem unintuitive since it is incremental relative to a threshold. For example, a hypoglycemia AOC of 1 mg/dl can denote a glucose of 60 mg/dl for 10% of the time (10 mg/dl below threshold * 10% = 1 mg/dl) or 65 mg/dl for 20% of the time (5 mg/dl below threshold * 20% = 1 mg/dl). Note that it is based on relative (%) rather than absolute time so there is no time element in the resulting units.
AOC 70 mg/dL - Main Phase, Day Only
Area Over the Curve (AOC) 70 mg/dL - Main Phase, day only (07:00 - 23:00). The hypoglycemia AOC is scaled to the number of CGM readings so the time factor cancels out. Technically, the units would be mg/dl, but this might seem unintuitive since it is incremental relative to a threshold. For example, a hypoglycemia AOC of 1 mg/dl can denote a glucose of 60 mg/dl for 10% of the time (10 mg/dl below threshold * 10% = 1 mg/dl) or 65 mg/dl for 20% of the time (5 mg/dl below threshold * 20% = 1 mg/dl). Note that it is based on relative (%) rather than absolute time so there is no time element in the resulting units.
HBGI - Main Phase, Day and Night
High Blood Glucose Index (HBGI) - Main Phase, Day and Night. The HBGI metric is used to quantify the risk of hyperglycemia. A higher HBGI implies more mild hyperglycemic events or less severe hyperglycemic events.
HBGI - Main Phase, Night Only
High Blood Glucose Index (HBGI) - Main Phase, night only (23:00 - 07:00). The HBGI metric is used to quantify the risk of hyperglycemia. A higher HBGI implies more mild hyperglycemic events or less severe hyperglycemic events.
HBGI - Main Phase, Day Only
High Blood Glucose Index (HBGI) - Main Phase, day only (07:00 - 23:00). The HBGI metric is used to quantify the risk of hyperglycemia. A higher HBGI implies more mild hyperglycemic events or less severe hyperglycemic events.
ADRR - Main Phase, Day and Night
Average Daily Risk Range (ADRR) - Main Phase, Day and Night. ADRR is a metric that categorizes risk for hyper and hypoglycemic events. Low risk is scored 0-19, moderate risk is scored 20-40, and high risk is 40 and above.
AUC 180 mg/dL - Main Phase, Day and Night
Area Under the Curve (AUC) 180 mg/dL - Main Phase, Day and Night. The hyperglycemic AUC is scaled to the number of CGM readings so the time factor cancels out. Technically, the units would be mg/dl, but this might seem unintuitive since it is incremental relative to a threshold. For example, the hyperglycemic AUC is 28 (mg/dl)*days for Patient A and 56 (mg/dl)*days for Patient B when using 180 as the threshold. But this is artificial because Patient B wore the sensor twice as long. So we similarly scale it relative to the number of readings to reflect a mean rather than a sum. So we say hyperglycemic AUC = 4 mg/dl for both patients. Note that time disappears from the units in the scaled version. It represents the mean value of max(glucose-180, 0).
AUC 180 mg/dL - Main Phase, Night Only
Area Under the Curve (AUC) 180 mg/dL - Main Phase, night only (23:00 - 07:00). The hyperglycemic AUC is scaled to the number of CGM readings so the time factor cancels out. Technically, the units would be mg/dl, but this might seem unintuitive since it is incremental relative to a threshold. For example, the hyperglycemic AUC is 28 (mg/dl)*days for Patient A and 56 (mg/dl)*days for Patient B when using 180 as the threshold. But this is artificial because Patient B wore the sensor twice as long. So we similarly scale it relative to the number of readings to reflect a mean rather than a sum. So we say hyperglycemic AUC = 4 mg/dl for both patients. Note that time disappears from the units in the scaled version. It represents the mean value of max(glucose-180, 0).
AUC 180 mg/dL - Main Phase, Day Only
Area Under the Curve (AUC) 180 mg/dL - Main Phase, day only (07:00 - 23:00). The hyperglycemic AUC is scaled to the number of CGM readings so the time factor cancels out. Technically, the units would be mg/dl, but this might seem unintuitive since it is incremental relative to a threshold. For example, the hyperglycemic AUC is 28 (mg/dl)*days for Patient A and 56 (mg/dl)*days for Patient B when using 180 as the threshold. But this is artificial because Patient B wore the sensor twice as long. So we similarly scale it relative to the number of readings to reflect a mean rather than a sum. So we say hyperglycemic AUC = 4 mg/dl for both patients. Note that time disappears from the units in the scaled version. It represents the mean value of max(glucose-180, 0).
Time Spent >250 mg/dL - Main Phase, Day and Night
Percentage of CGM Measured Glucose Values >250 mg/dl during study Main Phase
Time Spent >250 mg/dL - Main Phase, Night Only
Percentage of CGM Measured Glucose Values >250 mg/dl during study Main Phase, night only (23:00 to 07:00)
Time Spent >250 mg/dL - Main Phase, Day Only
Percentage of CGM Measured Glucose Values >250 mg/dl during study Main Phase, day only (07:00 - 23:00)
Time Spent >300 mg/dL - Main Phase, Day and Night
Percentage of CGM Measured Glucose Values >300 mg/dl during study Main Phase
Time Spent >300 mg/dL - Main Phase, Night Only
Percentage of CGM Measured Glucose Values >300 mg/dl during study Main Phase, night only (23:00 to 07:00)
Time Spent >300 mg/dL - Main Phase, Day Only
Percentage of CGM Measured Glucose Values >300 mg/dl during study Main Phase, day only (07:00 - 23:00)